FLORHAM PARK, N.J., Aug. 29 - Today PharmaDerm, a
division of Nycomed US, announced the launch of KEROL ZX and KEROL Emulsion
to the dermatology and podiatry markets. These specialty products have been
developed for improved treatment of dry skin and damaged nails:
— KEROL Emulsion (NDC#10337-646-10) is supplied in a 10oz. tube for
application to larger skin surface areas.
— KEROL ZX (NDC#10337-644-97) is now supplied in a 12 mL. pre-filled
applicator to deliver targeted relief to smaller areas such as nails,
corns, and calluses.
The KEROL products are indicated for debridement and promotion of
normal healing of hyperkeratotic surface lesions and contain a zinc
undecylate and lactic acid vehicle. They work by gently dissolving the
intercellular matrix, resulting in the loosening of the horny outer layer
of skin, and revealing healthy skin. They are indicated for hyperkeratotic
conditions such as dry rough skin, dermatitis, psoriasis, xerosis,
ichthyosis, eczema, keratosis pilaris, keratosis palmaris, keratoderma,
corns and calluses and damaged and devitalized nails.
“This is an exciting time at PharmaDerm as we build the only fully
integrated dermatology company in the U.S.,” said David Fink, General
Manager, PharmaDerm and Senior Vice President, Nycomed US. “The KEROL
family of products continues to evolve and improve. These new KEROL
products provide physicians and patients with a continuum of new treatment
options for dry skin and damaged nails.”
About PharmaDerm
PharmaDerm, a division of Nycomed US, is a specialty pharmaceutical
company dedicated to developing and commercializing prescription products
to treat diseases and conditions of the skin-the largest organ of the human
body. Our goal is to pursue development of products that will help improve
the lives of patients with skin disease.
Nycomed US is a leading manufacturer of topical prescription products
pharmaceutical products in the United States and is uniquely positioned as
a fully integrated specialty pharmaceutical company dedicated to skin
disease with in-house expertise and facilities for formulation development,
clinical development, manufacturing, distribution, sales and marketing.
KEROL(TM) Emulsion and KEROL(TM) ZX are for external use only. Avoid
contact with eyes, lips or mucous membranes. Transient stinging, burning,
itching or irritation may occur and normally disappear on discontinuing the
medication.
SOURCE PharmaDerm